Core Viewpoint - Future Health, the parent company of SKG, has officially terminated its IPO plans on the Beijing Stock Exchange due to strategic development needs, following a series of challenges in its previous IPO attempts [2][4]. Group 1: Company Overview - Future Health was established in 2007 and has evolved into a high-tech enterprise providing smart wearable health products, with its main brand being SKG, focusing on products like neck and eye massagers, and health watches [2][3]. - As of September 2023, over 80% of the company's revenue comes from wearable health products, with neck and waist massagers being the most significant product lines [3]. Group 2: Financial Performance - Future Health's revenue from 2021 to 2024 was as follows: 1.054 billion, 904 million, 1.046 billion, and 1.048 billion yuan, while net profits were 131 million, 119 million, 127 million, and 135 million yuan respectively [3]. - The company has faced scrutiny regarding its high cash dividends, which were 155 million and 160 million yuan in 2020 and 2021, exceeding its net profits for those years [5]. Group 3: IPO Journey - Future Health's IPO journey has been tumultuous, with multiple attempts and rejections, including a failed application for the ChiNext board in 2022 and a subsequent withdrawal of its application in July 2023 [4][6]. - The company had initially aimed to raise 1.6 billion yuan but later reduced its target to 1.29 billion yuan [4]. Group 4: International Expansion - In recent years, Future Health has focused on expanding its international presence, particularly through its SKG brand, which has increased investments in cross-border e-commerce platforms [7]. - The company signed a strategic investment agreement with Morgan Stanley, securing a significant investment to accelerate its overseas expansion [7]. - Despite increased marketing expenditures, the company's overseas revenue saw a decline of 14.18% in the first half of 2024, amounting to approximately 28.54 million yuan [8].